A new clinical trial funded by Breakthrough T1D recently launched and is testing islet cell transplantation paired with Eledon Pharmaceuticals’ investigational immunosuppression therapy tegoprubart in ...
A new clinical trial is investigating tegoprubart with islet cell transplants in people with type 1 diabetes and kidney disease.
Read all the updates from day 2 of Breakthrough T1D's Clinical and Research Congress focused entirely on type 1 diabetes.
Breakthrough T1D’s first-ever Clinical and Research Congress (CRC), focused entirely on type 1 diabetes (T1D), has come to a ...
What’s Happening? A new Breakthrough T1D-funded clinical trial investigating Eledon Pharmeceuticals’ immunotherapy, tegoprubart, with islet cell transplants in people with type 1 diabetes (T1D) and ...
PHILADELPHIA, Pa., Oct. 12, 2026 – Breakthrough T1D, formerly JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, announces the conclusion of the inaugural Breakthrough ...
National Diabetes Awareness Month is the perfect time to see what’s next in type 1 diabetes (T1D) research. On Sunday, November 15, Breakthrough T1D invites you to a free research update at the ...
Even though we could not gather together in Boston and Maine, the work you have done and the funds you have raised continue to make a real difference for the type 1 diabetes (T1D) community. We know ...
The Breakthrough T1D Youth Ambassador Program (YA) was designed to cultivate youth leaders within the type 1 diabetes (T1D) community. Youth Ambassadors inspire others by sharing their T1D stories, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results